Synthesis and biological evaluation of new clofibrate analogues as potential PPARα agonists

…, E Santandrea, N Dell'Uomo, F Giannessi…

文献索引：Perrone, Maria Grazia; Santandrea, Ernesto; Dell'Uomo, Natalina; Giannessi, Fabio; Milazzo, Ferdinando Maria; Sciarroni, Anna Floriana; Scilimati, Antonio; Tortorella, Vincenzo European Journal of Medicinal Chemistry, 2005 , vol. 40, # 2 p. 143 - 154

全文：HTML全文

被引用次数: 19

摘要

Clofibrate is a lipid-profile modifying agent belonging to the fibrate class of drugs. Fibrates are known to exhibit their beneficial effects by activating peroxisome proliferator-activated receptor-α (PPARα) and used in the treatment of dyslipidemia and atherosclerosis and for the prevention of heart failure. Hereby, the preparation of two new sets of clofibrate analogues, ethyl 2-(4-chlorophenoxy)-3-oxoalkanoates and ethyl 2-(4-chlorophenoxy)-3- ...